Aggravating influence of atomoxetine on the severity of stuttering and its successful treatment with methylphenidate: a case report

Cicek A.

DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, cilt.33, sa.2, ss.210-213, 2020 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 2
  • Basım Tarihi: 2020
  • Doi Numarası: 10.14744/dajpns.2020.00081
  • Dergi Adı: DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, Psycinfo, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.210-213
  • Anahtar Kelimeler: Atomoxetine, attention deficit hyperactivity disorder, child/adolescent, methylphenidate, stuttering, NOREPINEPHRINE TRANSPORTER
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Stuttering is a communication disorder characterized by a disruption in normal fluency and time patterning of speech. None of the pharmacological agents for stuttering could be recommended for general use; specific drug treatment that is simultaneously effective for both stuttering and attention deficit hyperactivity disorder (ADHD) is currently unknown. In this article, we present a case affected by severe developmental stuttering and ADHD that was exacerbated by atomoxetine but favorably responded to treatment with methylphenidate.